Navigation Links
Absorption Pharmaceuticals Expands Sales and Service Team to Answer Physicians' Growing Demand for Promescent
Date:11/21/2013

LOS ANGELES, Nov. 21, 2013 /PRNewswire/ -- Absorption Pharmaceuticals (AP), the innovators behind Promescent, announced today the addition of three new experts to their national sales and support team to better cater to its growing demand from urologists and pharmacies. Word of Promescent's superior efficacy, minimal side effects, ease-of-use, and low cost per dose for treating premature ejaculation is spreading fast, so in an effort to solidify continued success and satisfaction, the company has recruited some of the most knowledgeable and qualified salespersons in the field to join their team. 

"Only 9% of men with PE seek help from their physician, so there's a lack of knowledge among patients and many urologists with the causes and latest treatment options for PE," says Jeff Abraham, CEO of Absorption Pharmaceuticals. "It's critical that our sales and service team have the experience in sexual medicine to efficiently educate physicians, PAs, and pharmacists."

Lisa Waddington joins AP as the director of Eastern U.S. regional sales, based in New York City.  She comes to AP from Bryce Rx Laboratories, one of the nation's compounding-only pharmacies, which specialized in erectile dysfunction. Lisa developed Bryce Rx's distribution of advanced ED medications, including Trimix, with hundreds of urologists across the United States.

Victoria Skrip joins AP as the director of Midwest U.S. regional sales, based in Chicago. Prior to AP, she was an award-winning urology and women's health care representative for Warner Chilcott Pharmaceuticals, based in Louisville, Kentucky.

Mary Ann Adkins joins AP as the director of physician services, based in Las Vegas. Mary Ann has extensive experience in sexual medicine, particularly with solutions following radical prostatectomy to help men regain sexual function.  She understands the physician, PA, and administrative staff goals for patient care and will bring that perspective to AP.

"I'm excited to add Lisa, Victoria and Mary Ann to the team," concludes Abraham. "Not only do they provide additional geographic coverage, but each of them provides new knowledge in the field of sexual medicine that strengthens the company's ability to serve both patient and physician."

Already, there are more than one thousand urologists across the U.S. currently using Promescent as first-line treatment for premature ejaculation, and its popularity is now also surging among sex therapists and even general practitioners.  With three sterling new additions to their sales force, Absorption Pharmaceuticals can now extend their aid and reach even further.

About Absorption Pharmaceuticals
Absorption Pharmaceuticals is the maker of Promescent, an FDA-approved, topical medication for premature ejaculation. Many key opinion leaders in sexual medicine consider Promescent the leading solution for premature ejaculation in the U.S. The California-based company has been featured in numerous media including CNBC, NBC News, Dr. Oz, the Doctors, CNN and the National Post. Learn more at www.promescent.com.

For more information, or to purchase Promescent, please visit https://www.promescent.com/.


'/>"/>
SOURCE Absorption Pharmaceuticals
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Absorption Systems Scientists Publish Peer-reviewed Paper on a Key Drug Transporter
2. Lexicon Presents Preclinical Data On LX2761, a New Clinical Candidate for Diabetes Designed to Reduce Glucose Absorption From Gastrointestinal Tract
3. Vatsala Naageshwaran of Absorption Systems to Present at Disso 2013 International Conference in Mumbai, India on May 3rd
4. Absorption Pharmaceuticals to Receive Patent for Premature Ejaculation Topical Medication
5. Absorption Systems Partners with Synerzys to Promote Biopharmaceutics Classification System (BCS) Testing of Drugs
6. Absorption Systems Registers with FDA as a Generic Drug Facility under GDUFA
7. Absorption Systems announces novel test platform for interactions with the BCRP transporter
8. Actinium Pharmaceuticals To Present At The LD Micro Conference
9. Acquisitions, Conference Participations, Court Rulings, and Product Deliveries - Research Report on Zoetis, Aegerion Pharmaceuticals, Edwards, Community Health Systems, and Air Methods
10. Financial Results, Agreements, Meetings, and Clinical Trials - Research Report on Cell Therapeutics, Akorn, Ligand, Intercept Pharmaceuticals and Ariad Pharmaceuticals
11. Immune Pharmaceuticals Reports Third Quarter 2013 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/20/2017)... Avillion LLP, a co-developer and financier of late-stage pharmaceutical ... MBA as Chief Medical Officer. Dr Weinberg will be based in ... ... more than 17 years as a pharmaceutical and biotech executive with ... the course of his career, he has interfaced with the US ...
(Date:1/19/2017)... YORK , Jan. 19, 2017 The ... provides understanding and access to partnering deals and agreements ... - Trends in partnering deals - Top deals by ... stage of development, technology type The report provides ... entered into by the world,s leading healthcare companies. ...
(Date:1/19/2017)... 19, 2017 This report on the opioid ... scenario of the global market. Large number of chronic ... chronic constipation is a major side effect of consumption ... novel targeted therapy has been prescribed to treat opioid ... targeted medicines, and growing awareness about the therapy are ...
Breaking Medicine Technology:
(Date:1/20/2017)... ... , ... Source Vitál Apothecary, a skin and body care company dedicated to ... had a successful visit to the 2017 ECRM Diet, Vitamin & Sports Nutrition Conference ... the nutritional, sports and health industries a chance to meet in private sessions with ...
(Date:1/20/2017)... ... January 20, 2017 , ... Lice Troopers, the lice ... in families with school-aged children since the holiday season. , “It happens every ... their families, sharing hugs and taking photos, which is the head-to-head gateway that lice ...
(Date:1/20/2017)... boca raton florida (PRWEB) , ... January 20, 2017 , ... ... trial at the Dana Farber Cancer Institute. For Betsy, the clinical trial has ... and her cancer has not worsened. , Betsy Brauser was diagnosed with ovarian ...
(Date:1/20/2017)... (PRWEB) , ... January 20, 2017 , ... “Mary Magdalene: ... the mysterious life of the woman who witnessed Jesus Christ firsthand. “Mary Magdalene: Grace ... denizen, who spent her career as an educator interacting with countless women who had ...
(Date:1/20/2017)... ... January 20, 2017 , ... “I Forgive You”: a fine examination of how ... You” is the creation of published author, Stephen Miller, who, for over ten long years ... given to him. Born in Trinidad and Tobago, he has been serving the Lord for ...
Breaking Medicine News(10 mins):